Search
Studies * EuroSIDA * Publications * 2012


EuroSIDA publications 2012

 

1 Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy. JD Kowalska, J Reekie, A Mocroft, P Reiss, B Ledergerber, J Gatell, AD Monforte, A Phillips, JD Lundgren, O Kirk; for the EuroSIDA study group.
AIDS. 2012 Jan 28;26(3):315-323. Epub ahead of print 2011 Nov 22. abstract

2 Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes : A cohort study. D Costagliola, R Lodwick, B Ledergerber, C Torti, A van Sighem, D Podzamcer, A Mocroft, et al. The Pursuing Later Treatment Option II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group.
Lancet Infect Dis. 2012 Feb;12(2):119-127. Epub ahead of print 2011 Oct 7. abstract

3 Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA Study. J Reekie, JD Kowalska, I Karpov, J Rockstroh, A Karlsson, A Rakhmanova, A Horban, O Kirk, JD Lundgren, A Mocroft; for EuroSIDA in EuroCoord.
PLoS One. 2012;7(7):e41673. article

4 Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study. D Podlekareva, J Reekie, A Mocroft, M Losso, A Rakhmanova, E Bakowska, IA Karpov, J Lazarus, J Gatell, JD Lundgren, O Kirk.
BMC Infect Dis. 2012 Sep 25;12(1):229. abstract article

5 HCV viremia increases the incidence of chronic kidney disease in HIV-infected patients. L Peters, D Grint, JD Lundgren, JK Rockstroh, V Soriano, P Reiss, A Grzeszczuk, H Sambatakou, A Mocroft, O Kirk; for EuroSIDA in EuroCoord.
AIDS. 2012 Sep 24;26(15):1917-1926. abstract

6 All-cause mortality in treated HIV-infected adults with CD4 >500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. C Lewden, V Bouteloup, S De Wit, C Sabin, A Mocroft,JC Wasmuth, A van Sighem, O Kirk, N Obel, G Panos, J Ghosn, F Dabis, M Mary-Krause, C Leport, S Perez-Hoyos, P Sobrino-Vegas, C Stephan, A Castagna, A Antinori,A d’Arminio Monforte, C Torti, C Mussini, V Isern, A Calmy, R Teira, M Egger, J Grarup, and G Chene.
Int J Epidemiol. 2012 Apr;41(2):433-45. abstract

7 Evaluation of HIV Protease Inhibitor Use and the Risk of Sudden Death or Nonhemorrhagic Stroke SW Worm, DA Kamara, P Reiss, E Fontas, S De Wit, W El-Sadr, A D´Arminio Monforte, M Law, A Phillips, L Ryom, NF Dabis, R Weber, C Sabin, JD Lundgren, and on behalf of the D:A:D Study Group
J Infect Dis. 2012 Feb 15;205(4):535-9. abstract

8 Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. K Petoumenos, SW Worm, E Fontas, R Weber, S De Wit, M Bruyand, P Reiss, W El-Sadr, A d'Arminio Monforte, N Friis-Møller, JD Lundgren, MG Law on behalf of the D:A:D Study Group.
Journal of the International AIDS Society 2012, 15:17426 article

9 CD4 cell count and the risk of AIDS or death in HIV-infected adults on cART with a suppressed viral load: A longitudinal cohort study from COHERE. J Young, M Psichogiou, L Meyer, S Ayayi, S Grabar, F Raffi, P Reiss, B Gazzard, M Sharland, F Gutierrez, N Obel, O Kirk, JM Miro, H Furrer, A Castagna, S De Wit, J Muñoz, J Kjær, C Colin, J Grarup, G Chêne, H Bucher.
PLoS Med. 2012 Mar;9(3):e1001194. abstract

10 The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression. A Mocroft, WP Bannister, O Kirk, JD Kowalska, P Reiss, A d'Arminio Monforte, J Gatell, M Fisher, H Trocha, A Rakhmanova, JD Lundgren; the EuroSIDA Study in EuroCoord.
Antivir Ther. 2012;17(7):1291-1300. abstract

11 Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration.
HCV working group of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
Antivir Ther. 2012;17(8):1541-50. Epub 2012 Jul 24. abstract

12 Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. MT May, RS Hogg, AC Justice, BE Shepherd, D Costagliola, B Ledergerber, R Thiébaut, MJ Gill, O Kirk, A van Sighem, MS Saag, G Navarro, P Sobrino-Vegas, F Lampe, S Ingle, JL Guest, HM Crane, A d'Arminio Monforte, JJ Vehreschild, JA Sterne; the Collaborating Cohorts and Study Groups.
Int J Epidemiol. 2012 Dec;41(6):1807-20. Epub 2012 Nov 12.abstract

13 The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. M Murray, RS Hogg, VD Lima, MT May, DM Moore, S Abgrall, M Bruyand, A d'Arminio Monforte, C Tural, MJ Gill, RJ Harris, P Reiss, A Justice, O Kirk, M Saag, CJ Smith, R Weber, J Rockstroh, P Khaykin, JA Sterne; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2012 Feb; 13(2):89-97.







Total EuroSIDA publications as of December 2012: 175

Godsexliv.com